The Multiple Roles of C-type Lectin Receptors in Cancer

Overview

Journal Front Oncol

Specialty Oncology

Date 2023 Dec 13

PMID 38090489

Authors

Qiao Li

Affiliations

Soon will be listed here.

Abstract

C-type lectin receptors are a family of immune response receptors that can bind with a broad repertoire of ligands. It can function as innative immune receptors to surveillance bacteria, fungi, and virus invasions. The expressions of C-type lectin receptors (CLRs) are found in different types of tumors. But the role of C-type lectin receptors in cancer is not fully elucidated. And the underlying mechanisms of CLRs in carcinogenesis and tumor development remained unknown. It is known that CLRs bind to the glycosylated antigen on the cancer cells, regulating cancer cell invasion, migration, and metastasis. Meanwhile, the recognition of tumor glycans by antigen-presenting cells can stimulate antitumor immune response and induce immune tolerance. Also, some types of CLRs can be used as diagnostic markers for tumor cells, suggesting that C-type lectin can function as a new tumor therapeutic target and potential biomarkers. Given the therapeutic potential of CLRs in tumor treatments and the emerging roles of CLR in the tumor hallmarks, the multiple roles of CLRs in cancer were summarized in this review.

Citing Articles

CLEC4D as a Novel Prognostic Marker Boosts the Proliferation and Migration of Gastric Cancer via the NF-κB/AKT Signaling Pathway.

Yang Y, Zhang M, Cai F, Ma G, Zhang R, Yin Y Int J Gen Med. 2024; 17:1923-1935.

PMID: 38736669 PMC: 11088047. DOI: 10.2147/IJGM.S458228.

References

Fu A, Yao B, Dong T, Chen Y, Yao J, Liu Y . Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell. 2022; 185(8):1356-1372.e26. DOI: 10.1016/j.cell.2022.02.027. View

Wang B, Kuroiwa J, He L, Charalambous A, Keler T, Steinman R . The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells. Ann N Y Acad Sci. 2009; 1174:6-17. PMC: 2933265. DOI: 10.1111/j.1749-6632.2009.04933.x. View

Dominguez-Soto A, Sierra-Filardi E, Puig-Kroger A, Perez-Maceda B, Gomez-Aguado F, Corcuera M . Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10. J Immunol. 2011; 186(4):2192-200. DOI: 10.4049/jimmunol.1000475. View

van Gisbergen K, Aarnoudse C, Meijer G, Geijtenbeek T, van Kooyk Y . Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin. Cancer Res. 2005; 65(13):5935-44. DOI: 10.1158/0008-5472.CAN-04-4140. View

van Kooyk Y . C-type lectins on dendritic cells: key modulators for the induction of immune responses. Biochem Soc Trans. 2008; 36(Pt 6):1478-81. DOI: 10.1042/BST0361478. View

Fiorentini C, Carlini F, Germinario E, Maroccia Z, Travaglione S, Fabbri A . Gut Microbiota and Colon Cancer: A Role for Bacterial Protein Toxins?. Int J Mol Sci. 2020; 21(17). PMC: 7504354. DOI: 10.3390/ijms21176201. View

Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M . Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001; 345(11):784-9. DOI: 10.1056/NEJMoa001999. View

Gringhuis S, Dunnen J, Litjens M, van Het Hof B, van Kooyk Y, Geijtenbeek T . C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity. 2007; 26(5):605-16. DOI: 10.1016/j.immuni.2007.03.012. View

Merlotti A, Lopez Malizia A, Michea P, Bonte P, Goudot C, Carregal M . Aberrant fucosylation enables breast cancer clusterin to interact with dendritic cell-specific ICAM-grabbing non-integrin (DC-SIGN). Oncoimmunology. 2019; 8(9):e1629257. PMC: 6685524. DOI: 10.1080/2162402X.2019.1629257. View

10.

Taylor P, Gordon S, Martinez-Pomares L . The mannose receptor: linking homeostasis and immunity through sugar recognition. Trends Immunol. 2005; 26(2):104-10. DOI: 10.1016/j.it.2004.12.001. View

11.

Ren C, Leng R, Fan Y, Pan H, Li B, Wu C . Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value. Oncol Rep. 2017; 38(2):886-898. PMC: 5561967. DOI: 10.3892/or.2017.5738. View

12.

Choi K, Kashyap P, Dutta N, Stoltz G, Ordog T, Shea Donohue T . CD206-positive M2 macrophages that express heme oxygenase-1 protect against diabetic gastroparesis in mice. Gastroenterology. 2010; 138(7):2399-409, 2409.e1. PMC: 2883675. DOI: 10.1053/j.gastro.2010.02.014. View

13.

Bloem K, Vuist I, van den Berk M, Klaver E, Van Die I, Knippels L . DCIR interacts with ligands from both endogenous and pathogenic origin. Immunol Lett. 2013; 158(1-2):33-41. DOI: 10.1016/j.imlet.2013.11.007. View

14.

McDonald D, Wu L, Bohks S, KewalRamani V, Unutmaz D, Hope T . Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science. 2003; 300(5623):1295-7. DOI: 10.1126/science.1084238. View

15.

Kim M, Choi J, Tae N, Wi T, Kim K, Kim D . Novel Antibodies Targeting MUC1-C Showed Anti-Metastasis and Growth-Inhibitory Effects on Human Breast Cancer Cells. Int J Mol Sci. 2020; 21(9). PMC: 7247325. DOI: 10.3390/ijms21093258. View

16.

East L, Isacke C . The mannose receptor family. Biochim Biophys Acta. 2002; 1572(2-3):364-86. DOI: 10.1016/s0304-4165(02)00319-7. View

17.

Valdez H, Marin Franco J, Gorgojo J, Alvarez Hayes J, Balboa L, Fernandez Lahore M . Human macrophage polarization shapes B. pertussis intracellular persistence. J Leukoc Biol. 2021; 112(1):173-184. DOI: 10.1002/JLB.4A0521-254R. View

18.

Le Cabec V, Emorine L, Toesca I, Cougoule C, Maridonneau-Parini I . The human macrophage mannose receptor is not a professional phagocytic receptor. J Leukoc Biol. 2005; 77(6):934-43. DOI: 10.1189/jlb.1204705. View

19.

Nonaka M, Yong Ma B, Imaeda H, Kawabe K, Kawasaki N, Hodohara K . Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) recognizes a novel ligand, Mac-2-binding protein, characteristically expressed on human colorectal carcinomas. J Biol Chem. 2011; 286(25):22403-13. PMC: 3121387. DOI: 10.1074/jbc.M110.215301. View

20.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View